hallucinations/sarkom

Länken sparas på Urklipp

ArtiklarKliniska testerPatent

Välj sorteringstyp

9 resultat

Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Ifosfamide given to 42 patients iv at 2-2.5 g/m2/day X 4 resulted in partial responses in ten of 28 (36%) evaluable patients with adult soft tissue sarcomas, including two of two with chondrosarcoma; none of nine with pediatric sarcomas (Ewing's sarcoma, osteogenic sarcoma, or rhabdomyosarcoma)

Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Cytomegalovirus (CMV) central nervous system involvement is uncommon and hardly diagnosed because it can mimic many different conditions. We here present a case of an HIV-positive patient with neurological signs and symptoms (headache, asthenia, confusion, hallucinations, ataxia) with concurrent

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

OBJECTIVE Ifosfamide is metabolized by the cytochrome P450 system to its active form, ifosforamide mustard. A potential side effect is neurotoxicity, often manifesting as confusion, hallucination, or seizure. Aprepitant, a neurokinin-1 inhibitor, is recommended for highly and moderately emetogenic

Phase II trial of ifosfamide in children with malignant solid tumors.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Ifosfamide was given to 61 patients with malignant solid tumors diagnosed before the age of 21 years. In this phase II study, all patients received 1.6 g/m2/day X 5 iv over 15 minutes followed by mesna at a dose of 400 mg/m2 iv at 15 minutes and 4 and 6 hours after ifosfamide. Responses were

[Neurologic complications accompanying acquired immunodeficiency syndrome (AIDS): study of a group of 8 cases].

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Eight patients with acquired immune deficiency syndrome (AIDS) presented complications affecting the nervous system. The complaints were headache, seizure, confusion or hallucination. Neurologic manifestations included meningitis, focal deficits, cranial nerve palsy, and dementia. Cerebrospinal

Ifosfamide encephalopathy and nonconvulsive status epilepticus.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Ifosfamide (IFX), an alkylating agent and isomer of cyclophosphamide, is used as a single agent or a component of multi-agent chemotherapy in the treatment of ovarian, testicular, head and neck cancers, sarcomas and lymphomas. Encephalopathy is manifested by cerebellar ataxia, confusional

Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

In two sequential trials, 154 patients were treated with dosages of ifosfamide, ranging between 8 and 18 g/m2 divided over 4 days, with mesna uroprotection. The first was a phase II efficacy trial in 125 advanced sarcoma patients (Antman et al: J Clin Oncol 7:126-131, 1989), while the second was a

Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Ifosfamide is an alkylating agent used to treat different types of malignancies including lymphomas, sarcomas and germinal cell tumors. Symptoms of ifosfamide neurotoxicity can range from mild confusion, dizziness and hallucination to overt encephalopathy. Various treatment options like methylene

High-dose ifosfamide with mesna uroprotection: a phase I study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Phase II trials of ifosfamide have been performed with standard doses of 5 to 8 g/m2/course. In this phase I study, 29 patients were treated with a 4-day continuous infusion ifosfamide to determine the maximum-tolerated dose and the nonhematologic dose-limiting toxicity. Autologous bone marrow

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning